Perbedaan Organon Pharma Indonesia Tbk. dan Sumber Tani Agung Resources Tbk: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Sumber Tani Agung Resources Tbk diperdagangkan di Rp1.190 (kapitalisasi pasar 13,74 T, volume 24 jam 4,09 jt). Perbedaan utamanya: Sumber Tani Agung Resources Tbk jauh lebih besar — sekitar 131,6× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | STAA | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 13,74 T |
Volume | — | 4,09 jt |
Lot | — | 40,89 rb |
Perputaran | — | 5,01 M |
Harga Rata-rata | — | 1.226,35 |
Nilai Transaksi | — | 5,01 M |
Harga Ekuilibrium Indikatif | — | 1.190 |
Volume Ekuilibrium Indikatif | — | 1,22 rb |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →PT Sumber Tani Agung Resources Tbk (the Company) (formerly PT Sinarlika Portibijaya Plantation) was established on July 31, 1993 based on the Notarial Deed No. 189 of Reny Helena Hutagalung, S.H., Notary in Medan. The Company has operated its palm oil processing factory since May 2010.
Selengkapnya di halaman STAA →